Foghorn Therapeutics Inc. has entered into a significant lease agreement with ARE-MA Region No. 77, LLC for a space comprising 72,846 square feet at 99 Coolidge Avenue, Watertown, MA. The premises will be utilized for the company's principal executive offices as well as research, development, and manufacturing operations. The lease is set to commence on July 16, 2025, with the rent beginning to accrue on October 1, 2026. The lease will run for a period of 108 months from the start of the first full month following the Rent Commencement Date, unless terminated earlier. This strategic move is anticipated to support Foghorn Therapeutics' growth and operational needs.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.